关注
Hemant Rathi
Hemant Rathi
Health Economist, Skyward Analytics Private Limited
在 skywardanalytics.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Cost-effectiveness analysis of arthroscopic injection of a bioadhesive hydrogel implant in conjunction with microfracture for the treatment of focal chondral defects of the …
G Papadopoulos, S Griffin, H Rathi, A Gupta, B Sharma, D van Bavel
Journal of Medical Economics, 1-16, 2022
62022
A Cost-Effectiveness Analysis of AcrySof IQ Vivity Intraocular Lens (IOL) from Private Health Fund Perspective in Australia
C Bala, P Athanasiov, J Holland, M Dhariwal, A Gupta, H Rathi
Clinical Ophthalmology, 2403-2412, 2022
62022
Cost-benefit analysis of a trifocal intraocular lens versus a monofocal intraocular lens from the patient’s perspective in the United States
J Berdahl, C Bala, M Dhariwal, H Rathi, R Gupta
Plos one 17 (11), e0277093, 2022
52022
The efficacy and safety of abatacept, adalimumab, etanercept and tocilizumab are comparable in polyarticular juvenile idiopathic arthritis
H Rathi, B Pennington, A Amadi, S Lister, K Nanuwa
Value in Health 18 (7), A636, 2015
52015
A cost-effectiveness analysis of AcrySof IQ vivity intraocular lens from private health fund perspective in Australia
P Athanasiov, C Bala, J Holland, M Dhariwal, A Gupta, H Rathi
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 49 (8), 878-879, 2022
32022
The economic impact of cardiovascular events in patients post myocardial infarction: UK Health care Perspective
M Jain, V Sonathi, H Rathi, SK Thomas, P Mollon
Value in Health 17 (7), A483-A484, 2014
32014
The state of cost-utility analysis in India: A systematic review
T Khurana, A Gupta, H Rathi
Perspectives in Clinical Research 12 (4), 179, 2021
22021
EE69 Cost Utility and Budget Impact Analyses of Closed Loop Upper Airway Stimulation (UAS) for the Treatment of Moderate to Severe Obstructive Sleep Apnea From an Australian …
H Rathi, A Gupta, S Griffin, G Papadopoulos
Value in Health 25 (12), S66, 2022
2022
MT11 A Cost-Effectiveness Analysis of Acrysof IQ Vivity Intraocular Lens (IOL) From Private Health Fund Perspective in Australia
C Bala, P Athanasiov, J Holland, M Dhariwal, K Mills, A Gupta, H Rathi, ...
Value in Health 25 (12), S380, 2022
2022
EE250 An Update of Systematic Review of Cost-Utility Studies Conducted From an Indian Perspective
U Gaba, D Mukhopadhyay, R Gupta, S Dongare, H Rathi
Value in Health 25 (12), S102, 2022
2022
EPH22 A Systematic Literature Review of the Epidemiology Associated With Human Monkeypox in Children and Adults in India
D Mukhopadhyay, S Dongare, R Gupta, H Rathi
Value in Health 25 (12), S195, 2022
2022
EE338 Cost-Effectiveness Analysis of Arthroscopic Injection of a Bioadhesive Hydrogel Implant in Conjunction with Microfracture for the Treatment of Focal Chondral Defects of …
G Papadopoulos, S Griffin, H Rathi, A Gupta, B Sharma
Value in Health 25 (7), S400, 2022
2022
PNS9 Estimating Incidence Progressed Patients in Partitioned Survival Models-a Comparison of Three Methodologies
H Rathi, M Aristides, A Gupta, S Crowley, S Duff, G Papadopoulos
Value in Health 24, S174, 2021
2021
PNS7 A Systematic Review of Cost Utility Studies Conducted from an Indian Perspective
T Khurana, A Gupta, H Rathi
Value in Health Regional Issues 22, S81, 2020
2020
PNS8 An Analysis of Utility Values USED in Cost Utility Studies Conducted from an Indian Perspective
T Khurana, A Gupta, H Rathi
Value in Health Regional Issues 22, S81-S82, 2020
2020
COST ANALYSIS OF AN INTRANASAL NALOXONE TAKE-HOME PROGRAM: AN AUSTRALIAN CASE STUDY
K Lynch, M Aristides, H Rathi, G Papadopoulos, A McGuire
DRUG AND ALCOHOL REVIEW 37, S48-S48, 2018
2018
A DE-NOVO Model to Predict Outcomes of a New Hypothetical Intervention to Reduce CV Risk in Post Mi Patients
M Jain, V Sonathi, H Rathi, A Bakuli, SK Thomas, P Mollon
Value in Health 17 (7), A558, 2014
2014
A denovo economic model to predict outcomes of a new hypothetical intervention to reduce CV risk in post MI patients
M Jain, V Sonathi, H Rathi, A Bakuli, SK Thomas, P Mollon
系统目前无法执行此操作,请稍后再试。
文章 1–18